[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.66.66. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
The World in Medicine
December 19, 2007

HIV Vaccine Concerns?

JAMA. 2007;298(23):2733. doi:10.1001/jama.298.23.2733-b

An experimental HIV vaccine used in an international trial may have increased the risk of HIV infection among vaccine recipients, according to reports in November at a special open meeting of the HIV Vaccine Trials Network in Seattle (http://www.hvtn.org). The phase 2 trial, which involved 3000 volunteers at high risk for HIV infection, was halted in late September after a preliminary analysis revealed the vaccine had failed to show efficacy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×